GyneFix – a frameless intrauterine device

Česká verzia

Authors: Tomáš Fait
Authors place of work: Gynekologicko-porodnická klinika, 1. LF UK a VFN Praha
Published in the journal: Prakt Gyn 2011; 15(2): 113-116
Category: PR Article

Summary

A frameless intrauterine device broadens the range of options available for intrauterine contraception. It is highly effective and is associated with a minimum of adverse effects. In comparison to the classical copper IUDs, it is, owing to its small size, better tolerated, does not intensify menstrual bleeding and requires smaller dilatation of the cervical canal.

Key words:
frameless intrauterine device

Zdroje

1. Fait T. Antikoncepce. Praha: Maxdorf 2008.

2. Odlind V. Long-term experience of a levonorgestrel-releasing intrauterine system. Eur J Contraception Reprod Health Care 1996; 1(4): 319–323.

3. Farley TM, Rosenberg MJ, Rowe PJ et al. Intrauterine devices and pelvic inflammatory disease: an international perspective. Lancet 1992; 339(8796): 785–788.

4. WHO task force on IUD for fertility regulation. IUD insertion following termination of pregnancy: a clinical trial of the TCu 220C, Lippes loop D, and copper 7. Stud Fam Plann 1983; 14(4): 99–108.

5. Roy S, Cooper D, Mishell DR Jr. Experience with three different models of the Copper T intrauterine contraceptive device in nulliparous women. Am J Obstet Gynecol 1974; 119(3): 414–417.

6. Wildemersch D. New intrauterine technologies for contraception and treatment in nulliparous/adolescent and parous women. FV V ObGyn 2009; 1(3): 223–232.

7. Sääv I, Aronsson A, Marions L et al. Cervical priming with sublingual misoprostol prior insertion of an intrauterine device in nulliparous women: a randomized controlled trial. Hum Reprod 2007; 22(10): 2647–2652.

8. Vrijens M, Lorein P, Acker Van P et al. No increased perforation rate with frameless, anchored copper-releasing IU and levonorgestrel-releasing IUS. Congres of ESG, Roma 2009.

9. Meirik O, Rowe PJ, Peregoudov A et al. The frameless copper IUD (GyneFix) and the TCu380A IUD: results of an 8-year multicenter randomized comparative trial. Contraception 2009; 80(2): 133–141.

10. Wildemeersch D, Batár I, Affandi B et al. The frameless intrauterine system for long-term, reversible contraception: a review of 15 years of clinical experience. J Obstet Gynaecol Res 2003; 29(3): 164–173.

11. Dennis J, Webb A, Kishen M. Introduction of the GyneFix intra-uterine device in the UK: client satisfaction survey and casenotes review. J Fam Plann Reprod Health Care 2001; 27(3): 139–144.

12. Cao X, Zhang W, Zhao X et al. Three-year efficacy and acceptability of the GyneFix 200 intrauterine system. Contraception 2004; 69(3): 207–211.

13. Wildemeersch D, Rowe PJ. Assessment of menstrual blood loss in Belgian users of the frameless copper-releasing IUD with copper surface are of 200 mm² and users of copper-levonorgestrel-releasing intrauterine system. Contraception 2004; 70(2): 169–172.